A study led by Mayo Clinic researchers and Health Core study found that asthmatic patients are more likely to benefit from oral controllers than inhaled corticosteroids.
Researchers examined 55,000 patients from eight health plans who had used at least one of six types of asthma control medications between 2003 to 2005.
It was reported that both oral and inhaled treatments offered comparable impacts on patient’s health condition and quality of life.
Among patients taking combination of inhaled corticosteroids and long acting beta agonists, the clinical results were better and had better quality of life. In group of patients who adhered to their medication were more likely to have an emergency treatment.